MedPath

Lansoprazole

Lansoprazole DR 15mg Capsules

Approved
Approval ID

c77da981-9260-fabd-e053-2a95a90aa71c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 17, 2022

Manufacturers
FDA

Advanced Rx Pharmacy of Tennessee, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lansoprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0148
Application NumberANDA091269
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lansoprazole
Product Specifications
Route of AdministrationORAL
Effective DateNovember 17, 2022
FDA Product Classification

INGREDIENTS (1)

LANSOPRAZOLEActive
Quantity: 15 mg in 1 1
Code: 0K5C5T2QPG
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lansoprazole - FDA Drug Approval Details